Abiomed, Inc.
ABMD · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $106 | $55 | $60 | $46 |
| Dep. & Amort. | $7 | $7 | $7 | $7 |
| Deferred Tax | -$1 | -$6 | -$5 | -$1 |
| Stock-Based Comp. | $16 | $13 | $12 | $12 |
| Change in WC | -$39 | -$1 | $2 | $14 |
| Other Non-Cash | -$75 | $1 | $2 | $12 |
| Operating Cash Flow | $13 | $68 | $79 | $90 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6 | -$7 | -$15 | -$6 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$151 | -$126 | -$217 | -$251 |
| Inv. Sales/Matur. | $258 | $141 | $139 | $78 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $102 | $8 | -$93 | -$180 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $2 | $0 | $9 |
| Stock Repurch. | -$112 | -$15 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$110 | -$24 | $5 | -$6 |
| Financing Cash Flow | -$110 | -$24 | $5 | -$6 |
| Forex Effect | -$3 | -$5 | -$3 | -$2 |
| Net Chg. in Cash | $2 | $48 | -$11 | -$98 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $180 | $133 | $144 | $242 |
| End Cash | $182 | $180 | $133 | $144 |
| Free Cash Flow | $8 | $61 | $64 | $84 |